GlassScriptPhysician profile
Ebba M Tsinopoulos
NPI 1104079029
$2,726.07
in general payments reported to CMS, 2019-2025
27 companies · $809 in 2025
The $809 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $507 · 2021: $51.43 · 2022: $322 · 2023: $343 · 2024: $358 · 2025: $809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,509.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reapplix INC. | $511.11 | 2024-2025 | 3c Patch Kit - Box |
| Smith+Nephew, INC. | $421.39 | 2019-2025 | Collagenase Santyl, Grafix Pl, Renasys Go V2 Home |
| Musculoskeletal Transplant Foundation INC. | $221.80 | 2019-2022 | |
| Kerecis Limited | $186.31 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Medline Industries LP | $180.19 | 2019-2023 | |
| Misonix INC | $168.36 | 2019-2020 | |
| Reddress USA, INC. | $135.03 | 2024 | |
| Hartmann USA, INC. | $107.96 | 2020-2023 | Zetuvit Plus |
| Grt US Holding, INC. | $104.23 | 2022 | |
| Paratek Pharmaceuticals, INC. | $84.26 | 2020-2025 | Nuzyra |
| Kci USA, INC. | $75.42 | 2019-2020 | |
| Solventum Corporation | $70.25 | 2024-2025 | Activ.A.C., Promogran Prisma, 3m Cavilon |
| Organogenesis INC. | $66.26 | 2023-2025 | Puraply, Apligraf |
| Coloplast Corp | $52.80 | 2024-2025 | |
| Inari Medical, INC. | $50.00 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $45.42 | 2019-2023 | |
| Cashflow Solutions, LLC | $40.70 | 2022-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Melinta Therapeutics, LLC | $32.39 | 2021 | |
| Mimedx Group, INC. | $25.95 | 2025 | |
| Medela LLC | $23.45 | 2019-2022 | |
| Hollister Incorporated | $21.43 | 2023 | Premier, Adapt Ceraring |
| Amniox Medical, INC. | $21.01 | 2020 | |
| Nabriva Therapeutics, Plc | $19.53 | 2022 | |
| Bioventus LLC | $19.29 | 2022 | |
| Aroa Biosurgery Incorporated | $17.87 | 2020 | |
| Tactile Systems Technology INC | $11.99 | 2019 | |
| Allergan, INC. | $11.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ebba Tsinopoulos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.